1. Saito, Yoshinobu, Yin, Dingzi, Kubota, Naoto, Wangensteen, Kirk J, Schwabe, Robert F. 2023. A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23. In Gastroenterology, 164, 1279-1292. doi:10.1053/j.gastro.2023.02.043. https://pubmed.ncbi.nlm.nih.gov/36894036/
2. Guo, Rong, Dong, Xiaotao, Chen, Feng, Hu, Gongcheng, Yao, Hongjie. 2024. TEAD2 initiates ground-state pluripotency by mediating chromatin looping. In The EMBO journal, 43, 1965-1989. doi:10.1038/s44318-024-00086-5. https://pubmed.ncbi.nlm.nih.gov/38605224/
3. Yoo, Hye-Been, Moon, Jin Woo, Kim, Hwa-Ryeon, Kim, Mi-Young, Roe, Jae-Seok. 2023. A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer. In Gastroenterology, 165, 133-148.e17. doi:10.1053/j.gastro.2023.02.049. https://pubmed.ncbi.nlm.nih.gov/36907523/
4. Je, Eun Mi, Choi, Youn Jin, Chung, Yeun Jun, Yoo, Nam Jin, Lee, Sug Hyung. 2014. TEAD2, a Hippo pathway gene, is somatically mutated in gastric and colorectal cancers with high microsatellite instability. In APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 123, 359-60. doi:10.1111/apm.12327. https://pubmed.ncbi.nlm.nih.gov/25557945/
5. Park, Sujin, Mossmann, Dirk, Chen, Qian, Heim, Markus H, Hall, Michael N. . Transcription factors TEAD2 and E2A globally repress acetyl-CoA synthesis to promote tumorigenesis. In Molecular cell, 82, 4246-4261.e11. doi:10.1016/j.molcel.2022.10.027. https://pubmed.ncbi.nlm.nih.gov/36400009/
6. Alder, Olivia, Cullum, Rebecca, Lee, Sam, Marra, Marco A, Hoodless, Pamela A. 2014. Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation. In Cell reports, 9, 261-271. doi:10.1016/j.celrep.2014.08.046. https://pubmed.ncbi.nlm.nih.gov/25263553/
7. Niu, Xia, Meng, Yanan, Cui, Jinjin, Wang, Yucheng, Wang, Lulu. 2023. Hepatic Stellate Cell- and Liver Microbiome-Specific Delivery System for Dihydrotanshinone I to Ameliorate Liver Fibrosis. In ACS nano, 17, 23608-23625. doi:10.1021/acsnano.3c06626. https://pubmed.ncbi.nlm.nih.gov/37995097/
8. Liu-Chittenden, Yi, Huang, Bo, Shim, Joong Sup, Liu, Jun O, Pan, Duojia. 2012. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. In Genes & development, 26, 1300-5. doi:10.1101/gad.192856.112. https://pubmed.ncbi.nlm.nih.gov/22677547/